Clinical Trials on Aorto-coronary Bypass Grafting in Switzerland

Total 8 results

University Hospital, Basel, Switzerland

Completed

Combined Use of a Novel Cardioplegic Formula With MPS® Versus Cardioplexol ® in Urgent Isolated CABG Using MiECC in Patients With Recent Acute Myocardial Infarction

Heart Attack | Coronary Artery Bypass Grafting (CABG) | Cardioplegia Solution Adverse Reaction

Switzerland
University Hospital, Basel, Switzerland

Completed

Combined Use of a Novel Cardioplegic Formula With Myocardial Protection System (MPS)® Versus Cardioplexol ® in Isolated Coronary Artery Bypass Grafting (CABG) Using MiECC; (MiECC)

Complication of Coronary Artery Bypass Graft | Complication of Extracorporeal Circulation

Switzerland
University Hospital, Basel, Switzerland

Completed

Combined Use of a Novel Cardioplegic Formula With MPS ® Using the MiECC in Isolated CABG Versus OPCABG (OPCBAG)

Complication of Coronary Artery Bypass Graft | Complication of Extracorporeal Circulation

Switzerland
University Hospital, Basel, Switzerland

Completed

Glycosylated Hemoglobin and Risk of Perioperative Major Cardiovascular Events in Diabetic Patients Undergoing Coronary Bypass Revascularization (HbA1c)

Diabetes Mellitus | Coronary Artery Bypass Graft | Cardiovascular Event

Switzerland
University Hospital, Basel, Switzerland

Recruiting

Diagnostic and Prognostic Value of Cardiac Biomarkers for Early Coronary Bypass Occlusion in Patients Undergoing Coronary Revascularization

Coronary Bypass Graft Occlusion

Switzerland, Croatia, Poland
University Hospital, Basel, Switzerland

Completed

Goal-orientated Therapy of Perioperative Disturbance in Hemostasis in Cardiac Surgery

Blood Coagulation Disorders | Coronary Artery Bypass Graft Triple Vessel

Switzerland
University Hospital, Basel, Switzerland

Completed

Aspirin Responsiveness and Outcome in Coronary Artery Bypass Graft (CABG) Surgery

Myocardial Ischemia | Thrombosis | Coronary Artery Bypass Graft Triple Vessel | Antithrombotic Drugs [Platelet-aggregation Inhibitors] Causing Adverse Effects in Therapeutic Use

Switzerland
Kips Bay Medical, Inc.

Unknown

The eMESH 1 Feasibility Study (eMESH 1)

Atherosclerosis of Autologous Vein Coronary Artery Bypass Graft(s)

United States, United Kingdom, Czech Republic, Netherlands, France, Italy, Switzerland

Clinical Trials on Aorto-coronary Bypass Grafting in Switzerland

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Spain

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations